A Study of LY3871801 in Healthy Asian and Non-Asian Participants

NCT05960851 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY3871801
DRUG: Placebo

Sponsor

Eli Lilly and Company